Skip to main content
. 2002 Apr;40(4):1413–1419. doi: 10.1128/JCM.40.4.1413-1419.2002

TABLE 1.

Oligonucleotides used in a ligation assay to detect mutations in HIV-1 pol associated with resistance to protease inhibitors

Drug(s) Codon Amino acid substitution Genotype detected Sequence (5′→3′)a
Nelfinavir 30 WTb dig-TATTAGATACAGGAGCAGATG
D30N Mutant f-TATTAGATACAGGAGCAGATA
Common p-ATACAGTATTAGAAGAAATGAAT-bio
88 WT dig-CCTGTCAACATAATTGGAAGAA
N88D Mutant f-CCTGTCAACATAATTGGAAGAG
Common p-ATCTGTTGACTCAGATTGGTTG-bio
Amprenavir 50 WT dig-AAACCAAAAATGATAGGGGGAA
I50V Mutant f-AAACCAAAAATGATAGGGGGAG
Common p-TTGGAGGTTTTATCAAAGTAAGA-bio
Ritonavir, indinavir, lopinavirc 82 WT dig-TATTAGTAGGACCTACACCTGT
V82A Mutant A f-TATTAGTAGGACCTACACCTGC
V82S Mutant S f-TATTAGTAGGACCTACACCTAG
V82T Mutant T f-TATTAGTAGGACCTACACCTAC
Common p-CAACATAATTGGAAGAAATCTGT-bio
Amprenavir, indinavir 84 WT dig-AGGACCTACACCTGTCAACA
Nelfinavir, ritonavir I84V Mutant f-AGGACCTACACCTGTCAACG
Saquinavir, lopinavirc Common p-TAATTGGAAGAAATCTGTTGACT-bio
Saquinavir, nelfinavir 90 WT dig-CAACATAATTGGAAGAAATCTGT
L90M Mutant f-CAACATAATTGGAAGAAATCTGA
Common p-TGACTCAGATTGGTTGCACTTT-bio
a

Bases comprising the codons of interest are in boldface type. dig, digoxigenin; f, fluorescein; p, phosphate; bio, biotin.

b

WT, wild-type.

c

Mutations associated with HIV-1 resistance to lopinavir in phenotypic susceptibility assays and with virologic failure in clinical trials (13; Harrigan et al., Antivir. Ther.; Kempf et al., Antivir. Ther.; Molla et al., Antivir. Ther.).